By Sarah Lewington
ESI Special Topics,
October 2003
Citing URL - http://www.esi-topics.com/fbp/2003/october03-SarahLewington.html
|
Sarah Lewington answers a
few questions about this month's fast breaking paper in the field of
Clinical Medicine.
From
•>>October 2003
Field:
Clinical Medicine
Article Title:
"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies"
Authors: Lewington,
S;Clarke, R;Qizilbash, N;Peto, R;Collins, R
Journal: LANCET
Volume: 360
Page: 1903-1913
Year: DEC 14 2002
* Radcliffe Infirm, CTSU, PSC Secretariat, Oxford OX2 6HE, England.
* Radcliffe Infirm, CTSU, PSC Secretariat, Oxford OX2 6HE, England.
|
Why
do you think your paper is highly cited?
Because it provides stronger evidence than ever before of the
relationship between blood pressure and the risk of coronary
heart disease (CHD) and stroke for people at any age. The study,
funded by the British Heart Foundation (BHF) and the Medical
Research Council (MRC), analyzed data from 61 worldwide
observational studies of blood pressure and mortality
demonstrating direct evidence of strong links to CHD and stroke.
Does
it describe a new discovery or a new methodology that's useful to
others?
Although the finding that blood pressure is a predictor of
vascular disease is not new, it was previously not fully
appreciated how strongly it was related to vascular mortality
even among people in their seventies and eighties, nor that the
relationship was so strong and continuous throughout regardless
of the initial level of blood pressure (down at least as far as
115/75 mm Hg).
Could
you summarize the significance of your paper in layman's terms?
Not only do the present analyses confirm that there is a
continuous relationship with risk throughout the normal range of
usual blood pressure (down at least as far as 115/75 mm Hg), but
they also demonstrate that within this range the usual blood
pressure is even more strongly related to vascular mortality
than had previously been supposed. Randomized trials (which
typically last only a few years) have shown that blood pressure
lowering can produce rapid reductions in vascular disease risk,
and this meta-analysis provides complementary evidence of the
even greater differences in risk that are likely to be produced
by really prolonged differences in blood pressure.
How
did you become involved in this research?
This work continued from an earlier analysis of cholesterol,
blood pressure, and stroke published in the Lancet in
1995.
Sarah Lewington, DPhil
Radcliffe Infirmary
Clinical Trial Service Unit & Epidemiological Studies Unit
University of Oxford, UK
|
ESI Special Topics,
October 2003
Citing URL - http://www.esi-topics.com/fbp/2003/october03-SarahLewington.html
|
|
|